Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G; Australian Ovarian Cancer Study Group; Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, Ness RB, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Tworoger SS, Whittemore AS, McGuire V, Sieh W, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Rossing MA, Doherty JA, Goodman MT, Carney ME, Lurie G, Wilkens LR, Kjær SK, Høgdall E, Cramer DW, Terry KL, Garcia-Closas M, Yang H, Lissowska J, Anton-Culver H, Ziogas A, Schildkraut JM, Berchuck A, Pharoah PD; Ovarian Cancer Association Consortium.
Amankwah EK, et al. Among authors: hogdall e.
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1028-31. doi: 10.1158/1055-9965.EPI-11-0053. Epub 2011 Mar 17.
Cancer Epidemiol Biomarkers Prev. 2011.
PMID: 21415361
Free PMC article.